Cyclo Therapeutics Inc CYTH:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/20/22 EDT
1.98quote price arrow down-0.07 (-3.41%)
Volume
26,605
52 week range
1.88 - 13.00
Loading...
  • Open2.06
  • Day High2.10
  • Day Low1.95
  • Prev Close2.05
  • 52 Week High13.00
  • 52 Week High Date06/10/21
  • 52 Week Low1.88
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap16.67M
  • Shares Out8.42M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-0.64
  • YTD % Change-46.92

KEY STATS

  • Open2.06
  • Day High2.10
  • Day Low1.95
  • Prev Close2.05
  • 52 Week High13.00
  • 52 Week High Date06/10/21
  • 52 Week Low1.88
  • 52 Week Low Date05/12/22
  • Market Cap16.67M
  • Shares Out8.42M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-0.64
  • YTD % Change-46.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.30
  • P/E (TTM)-0.86
  • Fwd P/E (NTM)-1.04
  • EBITDA (TTM)-14.273M
  • ROE (TTM)-109.37%
  • Revenue (TTM)1.59M
  • Gross Margin (TTM)89.48%
  • Net Margin (TTM)-900.94%
  • Debt To Equity (MRQ)0.97%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cyclo Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's...
Address
6714 Nw 16Th Street,, Suite B
Gainesville, FL
32653
United States

Top Peers

SYMBOLLASTCHG%CHG
TMBR
Timber Pharmaceuticals Inc
0.2606-0.0043-1.6233%
NAVB
Navidea Biopharmaceuticals Inc
0.8154-0.0846-9.40%
EVOK
Evoke Pharma Inc
0.2562-0.0438-14.60%
BXRX
Baudax Bio Inc
0.7601-0.0406-5.0706%
ACUR
Acura Pharmaceuticals Inc
0.348-0.182-34.3396%